(Q47826642)

English

Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.

scientific article published on 20 July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

1 reference

based on heuristic

inferred from title

2

object named as

Gideon Koren

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

author name string

Ori Goldberg

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

Daniella Landau

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

Eitan Lunenfeld

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

Ilan Matok

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

Amalia Levy

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

publication date

20 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

53

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

991-995

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

Prescription drug use in pregnancy.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Asymptomatic bacteriuria and symptomatic urinary tract infections during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

National patterns in the treatment of urinary tract infections in women by ambulatory care physicians

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Pharmaceutical agents and pregnancy in urology practice

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Hemolytic anemia in a newborn after maternal treatment with nitrofurantoin at the end of pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Nitrofurantoin and congenital abnormalities

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Maternal drug use in early pregnancy and infant cardiovascular defect

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Maternal drug use, fertility problems, and infant craniostenosis

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

The safety of metoclopramide use in the first trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Guidelines for case classification for the National Birth Defects Prevention Study

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.139

21 January 2018

Identifiers

10.1002/JCPH.139

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23873250

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47826642&oldid=1740056073"